averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZEB1
|
ENSG00000148516.17 | zinc finger E-box binding homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZEB1 | hg19_v2_chr10_+_31610064_31610159 | -0.27 | 6.4e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_7165662 | 61.72 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
chr19_+_38755042 | 59.01 |
ENST00000301244.7
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr19_+_38755203 | 58.82 |
ENST00000587090.1
ENST00000454580.3 |
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr8_+_144816303 | 56.29 |
ENST00000533004.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
chr17_-_39942940 | 54.86 |
ENST00000310706.5
ENST00000393931.3 ENST00000424457.1 ENST00000591690.1 |
JUP
|
junction plakoglobin |
chr19_-_12886327 | 48.83 |
ENST00000397668.3
ENST00000587178.1 ENST00000264827.5 |
HOOK2
|
hook microtubule-tethering protein 2 |
chr11_-_68518910 | 42.56 |
ENST00000544963.1
ENST00000443940.2 |
MTL5
|
metallothionein-like 5, testis-specific (tesmin) |
chr14_-_61747949 | 41.34 |
ENST00000355702.2
|
TMEM30B
|
transmembrane protein 30B |
chr16_-_4987065 | 39.19 |
ENST00000590782.2
ENST00000345988.2 |
PPL
|
periplakin |
chr19_+_35739782 | 36.62 |
ENST00000347609.4
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr19_+_35739597 | 34.66 |
ENST00000361790.3
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr15_+_41136586 | 34.02 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr19_+_35739631 | 31.57 |
ENST00000602003.1
ENST00000360798.3 ENST00000354900.3 |
LSR
|
lipolysis stimulated lipoprotein receptor |
chr14_+_75745477 | 30.42 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr19_-_3028354 | 30.02 |
ENST00000586422.1
|
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
chr19_+_35739897 | 29.91 |
ENST00000605618.1
ENST00000427250.1 ENST00000601623.1 |
LSR
|
lipolysis stimulated lipoprotein receptor |
chr6_+_7541808 | 28.92 |
ENST00000379802.3
|
DSP
|
desmoplakin |
chr17_+_20059302 | 28.86 |
ENST00000395530.2
|
SPECC1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr19_+_35739280 | 28.15 |
ENST00000602122.1
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr6_+_7541845 | 28.15 |
ENST00000418664.2
|
DSP
|
desmoplakin |
chr14_-_61748550 | 27.39 |
ENST00000555868.1
|
TMEM30B
|
transmembrane protein 30B |
chr17_-_39684550 | 26.64 |
ENST00000455635.1
ENST00000361566.3 |
KRT19
|
keratin 19 |
chr17_-_31204124 | 24.17 |
ENST00000579584.1
ENST00000318217.5 ENST00000583621.1 |
MYO1D
|
myosin ID |
chr16_+_226658 | 24.02 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr15_+_41136216 | 23.33 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr19_-_14016877 | 22.93 |
ENST00000454313.1
ENST00000591586.1 ENST00000346736.2 |
C19orf57
|
chromosome 19 open reading frame 57 |
chr7_-_16844611 | 22.83 |
ENST00000401412.1
ENST00000419304.2 |
AGR2
|
anterior gradient 2 |
chr16_+_68771128 | 22.54 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
chr6_-_136871957 | 22.07 |
ENST00000354570.3
|
MAP7
|
microtubule-associated protein 7 |
chr16_+_222846 | 21.58 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr1_-_201368653 | 20.21 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
chr1_-_201368707 | 20.04 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
chr7_+_150497491 | 19.89 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
chr1_+_3370990 | 19.68 |
ENST00000378378.4
|
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
chr8_-_90769422 | 19.53 |
ENST00000524190.1
ENST00000523859.1 |
RP11-37B2.1
|
RP11-37B2.1 |
chr7_+_150497569 | 19.21 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
chr8_+_95653427 | 19.02 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr14_+_75746340 | 18.73 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr19_-_6767516 | 18.72 |
ENST00000245908.6
|
SH2D3A
|
SH2 domain containing 3A |
chr20_+_44098346 | 18.44 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr1_-_153588765 | 18.18 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
chr17_+_1665345 | 18.18 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr17_+_73521763 | 18.08 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
chr1_-_209979375 | 18.03 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
chr1_-_153588334 | 18.01 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
chr16_+_55542910 | 17.60 |
ENST00000262134.5
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2 |
chr2_-_99224915 | 17.50 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
chr3_-_128712955 | 17.46 |
ENST00000265068.5
|
KIAA1257
|
KIAA1257 |
chr8_+_95653373 | 17.42 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr8_+_95653302 | 17.39 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
chr19_-_6767431 | 17.32 |
ENST00000437152.3
ENST00000597687.1 |
SH2D3A
|
SH2 domain containing 3A |
chr3_-_187388173 | 17.27 |
ENST00000287641.3
|
SST
|
somatostatin |
chr1_-_59043166 | 17.20 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
chr14_-_65409438 | 17.18 |
ENST00000557049.1
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal) |
chr19_+_58095501 | 17.18 |
ENST00000536878.2
ENST00000597850.1 ENST00000597219.1 ENST00000598689.1 ENST00000599456.1 ENST00000307468.4 |
ZIK1
|
zinc finger protein interacting with K protein 1 |
chr22_-_50312052 | 16.96 |
ENST00000330817.6
|
ALG12
|
ALG12, alpha-1,6-mannosyltransferase |
chr22_+_40390930 | 16.80 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
chr13_+_42031679 | 16.72 |
ENST00000379359.3
|
RGCC
|
regulator of cell cycle |
chr19_+_39897453 | 16.59 |
ENST00000597629.1
ENST00000248673.3 ENST00000594045.1 ENST00000594442.1 |
ZFP36
|
ZFP36 ring finger protein |
chr7_-_22396533 | 16.43 |
ENST00000344041.6
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr19_+_55587266 | 16.34 |
ENST00000201647.6
ENST00000540810.1 |
EPS8L1
|
EPS8-like 1 |
chr19_+_41509851 | 16.33 |
ENST00000593831.1
ENST00000330446.5 |
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
chrX_-_107018969 | 16.23 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr14_+_75746781 | 16.18 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr8_+_102504651 | 16.18 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
chr11_+_394196 | 16.14 |
ENST00000331563.2
ENST00000531857.1 |
PKP3
|
plakophilin 3 |
chr10_-_50747064 | 16.10 |
ENST00000355832.5
ENST00000603152.1 ENST00000447839.2 |
ERCC6
PGBD3
ERCC6-PGBD3
|
excision repair cross-complementing rodent repair deficiency, complementation group 6 piggyBac transposable element derived 3 ERCC6-PGBD3 readthrough |
chr1_-_153363452 | 15.81 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr15_+_74833518 | 15.74 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr1_-_160990886 | 15.68 |
ENST00000537746.1
|
F11R
|
F11 receptor |
chr6_+_41604747 | 15.67 |
ENST00000419164.1
ENST00000373051.2 |
MDFI
|
MyoD family inhibitor |
chr2_-_89340242 | 15.41 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr11_+_82612740 | 15.39 |
ENST00000524921.1
ENST00000528759.1 ENST00000525361.1 ENST00000430323.2 ENST00000533655.1 ENST00000532764.1 ENST00000532589.1 ENST00000525388.1 |
C11orf82
|
chromosome 11 open reading frame 82 |
chr20_+_44098385 | 15.34 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chr16_+_30710462 | 15.26 |
ENST00000262518.4
ENST00000395059.2 ENST00000344771.4 |
SRCAP
|
Snf2-related CREBBP activator protein |
chr6_-_36355513 | 15.22 |
ENST00000340181.4
ENST00000373737.4 |
ETV7
|
ets variant 7 |
chr9_+_130911770 | 15.18 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
chr2_+_90248739 | 15.15 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr11_-_417388 | 15.13 |
ENST00000332725.3
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr4_-_57522470 | 15.07 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
chr10_-_105452917 | 15.06 |
ENST00000427662.2
|
SH3PXD2A
|
SH3 and PX domains 2A |
chr2_+_90198535 | 15.05 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr3_+_153839149 | 15.04 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr1_+_62208091 | 14.93 |
ENST00000316485.6
ENST00000371158.2 |
INADL
|
InaD-like (Drosophila) |
chr6_+_151042224 | 14.91 |
ENST00000358517.2
|
PLEKHG1
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
chr19_+_35606692 | 14.74 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr11_-_417308 | 14.51 |
ENST00000397632.3
ENST00000382520.2 |
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr14_-_106330458 | 14.49 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
chr1_+_26503894 | 14.30 |
ENST00000361530.6
ENST00000374253.5 |
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1 |
chr14_-_65409502 | 14.17 |
ENST00000389614.5
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal) |
chr20_+_49348081 | 14.14 |
ENST00000371610.2
|
PARD6B
|
par-6 family cell polarity regulator beta |
chrX_-_40506766 | 13.94 |
ENST00000378421.1
ENST00000440784.2 ENST00000327877.5 ENST00000378426.1 ENST00000378418.2 |
CXorf38
|
chromosome X open reading frame 38 |
chr19_+_35607166 | 13.80 |
ENST00000604255.1
ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr4_-_165898768 | 13.69 |
ENST00000329314.5
|
TRIM61
|
tripartite motif containing 61 |
chr7_-_73038822 | 13.60 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
chr9_+_130911723 | 13.56 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
chr8_-_120651020 | 13.55 |
ENST00000522826.1
ENST00000520066.1 ENST00000259486.6 ENST00000075322.6 |
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr2_+_47596287 | 13.54 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
chr12_-_6484715 | 13.50 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr1_+_29213678 | 13.47 |
ENST00000347529.3
|
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
chr7_-_150497406 | 13.47 |
ENST00000492607.1
ENST00000326442.5 ENST00000450753.2 |
TMEM176B
|
transmembrane protein 176B |
chr10_-_62493223 | 13.17 |
ENST00000373827.2
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
chr16_-_68269971 | 12.99 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
chr12_-_91576561 | 12.96 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
chr1_+_29213584 | 12.92 |
ENST00000343067.4
ENST00000356093.2 ENST00000398863.2 ENST00000373800.3 ENST00000349460.4 |
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
chr2_-_24583314 | 12.90 |
ENST00000443927.1
ENST00000406921.3 ENST00000412011.1 |
ITSN2
|
intersectin 2 |
chr16_+_89753070 | 12.71 |
ENST00000353379.7
ENST00000505473.1 ENST00000564192.1 |
CDK10
|
cyclin-dependent kinase 10 |
chr11_+_121322832 | 12.52 |
ENST00000260197.7
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr2_-_89399845 | 12.51 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr7_-_73038867 | 12.46 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
chr3_-_49459865 | 12.44 |
ENST00000427987.1
|
AMT
|
aminomethyltransferase |
chr7_+_73242069 | 12.43 |
ENST00000435050.1
|
CLDN4
|
claudin 4 |
chr7_-_73184588 | 12.42 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
chr14_+_105781102 | 12.38 |
ENST00000547217.1
|
PACS2
|
phosphofurin acidic cluster sorting protein 2 |
chr6_-_36355486 | 12.31 |
ENST00000538992.1
|
ETV7
|
ets variant 7 |
chr12_-_91576429 | 12.30 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
chr1_-_21948906 | 12.25 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr7_-_149470297 | 12.10 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
chr4_-_186125077 | 12.07 |
ENST00000458385.2
ENST00000514798.1 ENST00000296775.6 |
KIAA1430
|
KIAA1430 |
chr2_-_86333244 | 12.06 |
ENST00000263857.6
ENST00000409681.1 |
POLR1A
|
polymerase (RNA) I polypeptide A, 194kDa |
chr5_+_156693159 | 12.01 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr5_+_156693091 | 11.88 |
ENST00000318218.6
ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr18_+_61143994 | 11.84 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr17_+_1665253 | 11.72 |
ENST00000254722.4
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr14_-_106209368 | 11.71 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr16_-_2908155 | 11.68 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
chr22_-_31741757 | 11.64 |
ENST00000215919.3
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1 |
chr16_-_28936493 | 11.64 |
ENST00000544477.1
ENST00000357573.6 |
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2 |
chr17_-_39743139 | 11.56 |
ENST00000167586.6
|
KRT14
|
keratin 14 |
chr22_+_23229960 | 11.53 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr5_-_79551838 | 11.42 |
ENST00000509193.1
ENST00000512972.2 |
SERINC5
|
serine incorporator 5 |
chr22_+_41777927 | 11.41 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
chr11_-_111781454 | 11.40 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr4_+_40058411 | 11.36 |
ENST00000261435.6
ENST00000515550.1 |
N4BP2
|
NEDD4 binding protein 2 |
chr2_-_71454185 | 11.35 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
chr17_-_74023291 | 11.27 |
ENST00000586740.1
|
EVPL
|
envoplakin |
chr1_+_60280458 | 11.26 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
chr5_-_149792295 | 11.22 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr2_+_90139056 | 11.15 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr4_+_166300084 | 11.15 |
ENST00000402744.4
|
CPE
|
carboxypeptidase E |
chr20_+_36149602 | 11.10 |
ENST00000062104.2
ENST00000346199.2 |
NNAT
|
neuronatin |
chr5_-_42811986 | 11.06 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
chr5_-_131132614 | 11.04 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
chr5_-_138725560 | 11.04 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
chr16_-_46865047 | 11.02 |
ENST00000394806.2
|
C16orf87
|
chromosome 16 open reading frame 87 |
chr19_+_35606777 | 11.01 |
ENST00000604404.1
ENST00000435734.2 ENST00000603181.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr7_+_102715315 | 11.01 |
ENST00000428183.2
ENST00000323716.3 ENST00000441711.2 ENST00000454559.1 ENST00000425331.1 ENST00000541300.1 |
ARMC10
|
armadillo repeat containing 10 |
chr4_+_85504075 | 10.99 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
chr15_-_102029873 | 10.99 |
ENST00000348070.1
ENST00000358417.3 ENST00000344273.2 |
PCSK6
|
proprotein convertase subtilisin/kexin type 6 |
chr14_+_102027688 | 10.98 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chr19_-_51512804 | 10.98 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
chr7_-_8301682 | 10.95 |
ENST00000396675.3
ENST00000430867.1 |
ICA1
|
islet cell autoantigen 1, 69kDa |
chr15_+_90777424 | 10.89 |
ENST00000561433.1
ENST00000559204.1 ENST00000558291.1 |
GDPGP1
|
GDP-D-glucose phosphorylase 1 |
chr2_-_89292422 | 10.88 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr17_-_38657849 | 10.87 |
ENST00000254051.6
|
TNS4
|
tensin 4 |
chr3_-_196065248 | 10.85 |
ENST00000446879.1
ENST00000273695.3 |
TM4SF19
|
transmembrane 4 L six family member 19 |
chr2_+_89901292 | 10.76 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr17_+_72428218 | 10.74 |
ENST00000392628.2
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr19_-_40324767 | 10.73 |
ENST00000601972.1
ENST00000430012.2 ENST00000323039.5 ENST00000348817.3 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
chr5_-_130970723 | 10.72 |
ENST00000308008.6
ENST00000296859.6 ENST00000507093.1 ENST00000510071.1 ENST00000509018.1 ENST00000307984.5 |
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
chr5_-_138725594 | 10.68 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
chr11_+_118401706 | 10.62 |
ENST00000411589.2
ENST00000442938.2 ENST00000359862.4 |
TMEM25
|
transmembrane protein 25 |
chr17_-_15244894 | 10.61 |
ENST00000338696.2
ENST00000543896.1 ENST00000539245.1 ENST00000539316.1 ENST00000395930.1 |
TEKT3
|
tektin 3 |
chr1_-_223537475 | 10.60 |
ENST00000344029.6
ENST00000494793.2 ENST00000366878.4 ENST00000366877.3 |
SUSD4
|
sushi domain containing 4 |
chr14_-_24036943 | 10.59 |
ENST00000556843.1
ENST00000397120.3 ENST00000557189.1 |
AP1G2
|
adaptor-related protein complex 1, gamma 2 subunit |
chr1_+_153330322 | 10.47 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr7_-_150497621 | 10.44 |
ENST00000434545.1
|
TMEM176B
|
transmembrane protein 176B |
chr9_+_131843377 | 10.36 |
ENST00000372546.4
ENST00000406974.3 ENST00000540102.1 |
DOLPP1
|
dolichyldiphosphatase 1 |
chr12_-_91576750 | 10.33 |
ENST00000228329.5
ENST00000303320.3 ENST00000052754.5 |
DCN
|
decorin |
chr16_+_68678739 | 10.33 |
ENST00000264012.4
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr1_+_156030937 | 10.29 |
ENST00000361084.5
|
RAB25
|
RAB25, member RAS oncogene family |
chr19_-_51504411 | 10.26 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
chr7_+_73242490 | 10.26 |
ENST00000431918.1
|
CLDN4
|
claudin 4 |
chr19_+_42212501 | 10.18 |
ENST00000398599.4
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5 |
chr14_-_106330072 | 10.12 |
ENST00000488476.1
|
IGHJ5
|
immunoglobulin heavy joining 5 |
chr16_+_68679193 | 10.11 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr21_+_41239243 | 10.09 |
ENST00000328619.5
|
PCP4
|
Purkinje cell protein 4 |
chr3_-_49459878 | 10.05 |
ENST00000546031.1
ENST00000458307.2 ENST00000430521.1 |
AMT
|
aminomethyltransferase |
chr4_-_120550146 | 10.01 |
ENST00000354960.3
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific |
chr3_-_122283100 | 10.01 |
ENST00000492382.1
ENST00000462315.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr14_-_89878369 | 10.00 |
ENST00000553840.1
ENST00000556916.1 |
FOXN3
|
forkhead box N3 |
chr7_+_142498725 | 9.97 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
chr1_+_145439306 | 9.96 |
ENST00000425134.1
|
TXNIP
|
thioredoxin interacting protein |
chr14_+_76127529 | 9.95 |
ENST00000556977.1
ENST00000557636.1 ENST00000286650.5 ENST00000298832.9 |
TTLL5
|
tubulin tyrosine ligase-like family, member 5 |
chr7_-_8301768 | 9.95 |
ENST00000265577.7
|
ICA1
|
islet cell autoantigen 1, 69kDa |
chr2_+_17721920 | 9.93 |
ENST00000295156.4
|
VSNL1
|
visinin-like 1 |
chr22_+_29469100 | 9.92 |
ENST00000327813.5
ENST00000407188.1 |
KREMEN1
|
kringle containing transmembrane protein 1 |
chr22_-_44258360 | 9.91 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
chr3_-_46506358 | 9.90 |
ENST00000417439.1
ENST00000431944.1 |
LTF
|
lactotransferrin |
chr19_-_18632861 | 9.87 |
ENST00000262809.4
|
ELL
|
elongation factor RNA polymerase II |
chr22_+_45148432 | 9.83 |
ENST00000389774.2
ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8
|
Rho GTPase activating protein 8 |
chr19_+_42212526 | 9.78 |
ENST00000598976.1
ENST00000435837.2 ENST00000221992.6 ENST00000405816.1 |
CEA
CEACAM5
|
Uncharacterized protein carcinoembryonic antigen-related cell adhesion molecule 5 |
chr10_-_102790852 | 9.74 |
ENST00000470414.1
ENST00000370215.3 |
PDZD7
|
PDZ domain containing 7 |
chr12_+_56732658 | 9.72 |
ENST00000228534.4
|
IL23A
|
interleukin 23, alpha subunit p19 |
chr11_+_44587141 | 9.71 |
ENST00000227155.4
ENST00000342935.3 ENST00000532544.1 |
CD82
|
CD82 molecule |
chr20_+_31823792 | 9.70 |
ENST00000375413.4
ENST00000354297.4 ENST00000375422.2 |
BPIFA1
|
BPI fold containing family A, member 1 |
chr4_+_37455536 | 9.67 |
ENST00000381980.4
ENST00000508175.1 |
C4orf19
|
chromosome 4 open reading frame 19 |
chr9_+_91933726 | 9.65 |
ENST00000534113.2
|
SECISBP2
|
SECIS binding protein 2 |
chr13_-_45010939 | 9.58 |
ENST00000261489.2
|
TSC22D1
|
TSC22 domain family, member 1 |
chrX_-_48433275 | 9.58 |
ENST00000376775.2
|
AC115618.1
|
Uncharacterized protein; cDNA FLJ26048 fis, clone PRS02384 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
33.5 | 134.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
32.2 | 160.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
16.0 | 80.0 | GO:0002159 | desmosome assembly(GO:0002159) |
11.2 | 33.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
9.9 | 59.6 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
9.6 | 28.9 | GO:0032771 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
9.2 | 73.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
6.8 | 34.0 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
6.6 | 26.5 | GO:1900228 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
6.5 | 6.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
6.4 | 63.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
6.1 | 24.4 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
6.1 | 36.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
5.9 | 23.5 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
5.7 | 28.7 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
5.7 | 17.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
5.7 | 5.7 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
5.4 | 10.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
5.3 | 21.1 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
5.0 | 5.0 | GO:0071284 | cellular response to lead ion(GO:0071284) |
4.8 | 29.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
4.8 | 24.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
4.8 | 19.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
4.7 | 18.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
4.7 | 18.6 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
4.6 | 64.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
4.6 | 13.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
4.6 | 4.6 | GO:0009798 | axis specification(GO:0009798) |
4.6 | 4.6 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
4.5 | 63.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
4.5 | 22.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
4.4 | 17.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
4.4 | 4.4 | GO:0051885 | positive regulation of anagen(GO:0051885) |
4.4 | 17.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
4.3 | 12.8 | GO:0048627 | myoblast development(GO:0048627) |
4.2 | 12.7 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
4.2 | 29.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
4.1 | 16.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
4.1 | 28.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
4.1 | 12.4 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
4.1 | 4.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
4.1 | 12.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
4.0 | 12.1 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
4.0 | 15.9 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
3.9 | 15.8 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
3.8 | 3.8 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
3.8 | 22.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
3.8 | 109.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
3.8 | 3.8 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
3.8 | 11.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
3.8 | 11.3 | GO:0071810 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
3.7 | 3.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
3.6 | 3.6 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
3.6 | 14.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
3.6 | 14.2 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
3.5 | 17.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
3.5 | 28.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
3.5 | 14.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
3.5 | 3.5 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
3.4 | 10.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
3.4 | 23.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
3.4 | 13.6 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
3.4 | 3.4 | GO:0097384 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) cellular lipid biosynthetic process(GO:0097384) |
3.4 | 27.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
3.4 | 16.8 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
3.3 | 13.2 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
3.3 | 3.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
3.2 | 9.7 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
3.2 | 16.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
3.2 | 6.4 | GO:2000466 | negative regulation of glycogen (starch) synthase activity(GO:2000466) |
3.1 | 9.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) rRNA import into mitochondrion(GO:0035928) |
3.0 | 21.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
3.0 | 6.0 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
3.0 | 9.0 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of lactation(GO:1903487) |
3.0 | 35.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
3.0 | 8.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.9 | 5.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.9 | 20.6 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
2.9 | 8.8 | GO:0071529 | cementum mineralization(GO:0071529) |
2.9 | 8.7 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
2.8 | 22.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
2.8 | 2.8 | GO:0019835 | cytolysis(GO:0019835) |
2.8 | 36.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
2.8 | 8.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
2.8 | 5.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
2.8 | 11.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.8 | 8.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
2.8 | 19.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.8 | 8.3 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
2.7 | 8.2 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
2.6 | 7.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.6 | 2.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
2.6 | 5.2 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
2.6 | 5.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
2.6 | 7.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.5 | 14.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
2.5 | 7.4 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
2.5 | 7.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
2.5 | 9.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
2.5 | 19.7 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.4 | 43.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
2.4 | 7.1 | GO:0003383 | apical constriction(GO:0003383) mesoderm migration involved in gastrulation(GO:0007509) |
2.3 | 7.0 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
2.3 | 11.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
2.3 | 13.9 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
2.3 | 6.9 | GO:1902896 | terminal web assembly(GO:1902896) |
2.3 | 6.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.3 | 16.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.3 | 18.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
2.3 | 9.1 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
2.3 | 4.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
2.2 | 11.2 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
2.2 | 2.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
2.2 | 2.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
2.2 | 11.2 | GO:0030070 | insulin processing(GO:0030070) |
2.2 | 6.6 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
2.2 | 33.1 | GO:0015671 | oxygen transport(GO:0015671) |
2.2 | 13.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
2.2 | 8.7 | GO:0003335 | corneocyte development(GO:0003335) |
2.2 | 6.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
2.2 | 30.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
2.2 | 12.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
2.1 | 6.4 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
2.1 | 15.0 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
2.1 | 12.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
2.1 | 36.4 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
2.1 | 4.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.1 | 6.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
2.1 | 8.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
2.1 | 23.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
2.1 | 14.6 | GO:0009597 | detection of virus(GO:0009597) |
2.1 | 6.2 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
2.1 | 6.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
2.1 | 6.2 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
2.1 | 6.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
2.0 | 4.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.0 | 8.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
2.0 | 20.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
2.0 | 12.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.0 | 2.0 | GO:0072254 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
2.0 | 10.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
2.0 | 8.0 | GO:0015811 | L-cystine transport(GO:0015811) |
2.0 | 6.0 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
2.0 | 12.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
2.0 | 10.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
2.0 | 5.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
2.0 | 5.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.9 | 15.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.9 | 5.8 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
1.9 | 7.7 | GO:0019740 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
1.9 | 11.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.9 | 26.4 | GO:0035878 | nail development(GO:0035878) |
1.9 | 3.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
1.9 | 7.5 | GO:0060023 | soft palate development(GO:0060023) |
1.8 | 5.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
1.8 | 9.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.8 | 14.7 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.8 | 5.5 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
1.8 | 3.6 | GO:0070781 | response to biotin(GO:0070781) |
1.8 | 3.6 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
1.8 | 8.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.8 | 7.1 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
1.8 | 1.8 | GO:0030104 | water homeostasis(GO:0030104) multicellular organismal water homeostasis(GO:0050891) |
1.8 | 14.2 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
1.8 | 7.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.8 | 7.1 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
1.8 | 7.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.8 | 10.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
1.8 | 7.1 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.8 | 5.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.7 | 24.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.7 | 10.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.7 | 10.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
1.7 | 5.1 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
1.7 | 5.1 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
1.7 | 13.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.7 | 8.5 | GO:0060214 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
1.7 | 1.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.7 | 5.0 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
1.6 | 62.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
1.6 | 4.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.6 | 9.8 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.6 | 3.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.6 | 4.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.6 | 14.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.6 | 12.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.6 | 9.6 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.6 | 12.8 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
1.6 | 3.2 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
1.6 | 3.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
1.6 | 4.7 | GO:0002818 | intracellular defense response(GO:0002818) |
1.6 | 6.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.6 | 11.0 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
1.6 | 4.7 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
1.6 | 43.7 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
1.6 | 4.7 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.6 | 26.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.6 | 3.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.5 | 6.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.5 | 1.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.5 | 7.7 | GO:1902075 | cellular response to salt(GO:1902075) |
1.5 | 7.6 | GO:0046898 | response to cycloheximide(GO:0046898) |
1.5 | 3.0 | GO:0097581 | lamellipodium organization(GO:0097581) |
1.5 | 12.2 | GO:0015705 | iodide transport(GO:0015705) |
1.5 | 7.6 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.5 | 7.5 | GO:1903412 | response to bile acid(GO:1903412) |
1.5 | 5.9 | GO:0070384 | Harderian gland development(GO:0070384) |
1.5 | 8.9 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.5 | 10.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.5 | 4.4 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
1.5 | 10.4 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
1.5 | 220.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.5 | 14.7 | GO:0070673 | response to interleukin-18(GO:0070673) |
1.5 | 8.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.4 | 15.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.4 | 7.2 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
1.4 | 9.9 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
1.4 | 4.2 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.4 | 4.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
1.4 | 5.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
1.4 | 4.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.4 | 16.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.4 | 20.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.4 | 9.6 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.4 | 2.7 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.4 | 6.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.4 | 5.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.4 | 4.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.4 | 9.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.4 | 2.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.4 | 5.4 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.3 | 2.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.3 | 5.3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
1.3 | 4.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.3 | 6.6 | GO:0016926 | protein desumoylation(GO:0016926) |
1.3 | 6.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.3 | 3.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.3 | 6.5 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
1.3 | 16.8 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.3 | 3.9 | GO:0051697 | protein delipidation(GO:0051697) |
1.3 | 18.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
1.3 | 9.0 | GO:0044245 | polysaccharide digestion(GO:0044245) |
1.3 | 3.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.3 | 25.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.3 | 8.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.3 | 6.3 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
1.3 | 3.8 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
1.2 | 12.5 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
1.2 | 6.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
1.2 | 2.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.2 | 3.7 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
1.2 | 2.5 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
1.2 | 6.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
1.2 | 3.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.2 | 12.3 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
1.2 | 3.7 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
1.2 | 22.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.2 | 3.7 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.2 | 7.3 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
1.2 | 7.3 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
1.2 | 4.8 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
1.2 | 7.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
1.2 | 7.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
1.2 | 3.5 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
1.2 | 5.9 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
1.2 | 4.7 | GO:0021633 | optic nerve structural organization(GO:0021633) |
1.2 | 7.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.2 | 4.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.1 | 3.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.1 | 1.1 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
1.1 | 4.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.1 | 6.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
1.1 | 14.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.1 | 14.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.1 | 3.2 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
1.1 | 15.1 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
1.1 | 3.2 | GO:0097178 | ruffle assembly(GO:0097178) |
1.1 | 5.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
1.1 | 6.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
1.1 | 2.1 | GO:0031670 | cellular response to nutrient(GO:0031670) |
1.1 | 19.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
1.1 | 13.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.1 | 22.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.0 | 3.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.0 | 3.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
1.0 | 3.1 | GO:1903797 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) positive regulation of inorganic anion transmembrane transport(GO:1903797) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.0 | 26.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.0 | 13.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.0 | 4.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
1.0 | 48.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
1.0 | 4.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
1.0 | 5.1 | GO:0060174 | limb bud formation(GO:0060174) |
1.0 | 6.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.0 | 10.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.0 | 2.0 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
1.0 | 4.0 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
1.0 | 3.0 | GO:0021718 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
1.0 | 4.0 | GO:0035900 | response to isolation stress(GO:0035900) |
1.0 | 8.9 | GO:1903276 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
1.0 | 2.9 | GO:0032094 | response to food(GO:0032094) |
1.0 | 9.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.0 | 23.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.0 | 3.9 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
1.0 | 2.9 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
1.0 | 7.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.0 | 2.9 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
1.0 | 8.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.0 | 1.9 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.0 | 23.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
1.0 | 1.0 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.9 | 0.9 | GO:0030432 | peristalsis(GO:0030432) |
0.9 | 0.9 | GO:0035150 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
0.9 | 2.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.9 | 12.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.9 | 9.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.9 | 0.9 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.9 | 8.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.9 | 3.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.9 | 3.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.9 | 14.8 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.9 | 11.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.9 | 5.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.9 | 2.7 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.9 | 5.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.9 | 2.7 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.9 | 1.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.9 | 6.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.9 | 3.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.9 | 26.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.9 | 10.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.9 | 9.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.9 | 2.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 2.7 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.9 | 17.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.9 | 2.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.9 | 4.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.9 | 4.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.9 | 1.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.9 | 3.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.9 | 76.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.8 | 3.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.8 | 4.2 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.8 | 18.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.8 | 12.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.8 | 6.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 5.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.8 | 5.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.8 | 2.5 | GO:2000683 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) regulation of cellular response to X-ray(GO:2000683) positive regulation of cellular response to X-ray(GO:2000685) |
0.8 | 5.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.8 | 4.1 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.8 | 5.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.8 | 5.0 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.8 | 3.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.8 | 2.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.8 | 34.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.8 | 3.3 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.8 | 25.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.8 | 13.9 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.8 | 5.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.8 | 1.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.8 | 2.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.8 | 3.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.8 | 9.7 | GO:0036065 | fucosylation(GO:0036065) |
0.8 | 21.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.8 | 4.0 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.8 | 4.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.8 | 6.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.8 | 5.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.8 | 2.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.8 | 1.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.8 | 3.1 | GO:0046341 | CDP-diacylglycerol biosynthetic process(GO:0016024) CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 3.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 7.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.8 | 9.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.8 | 8.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.8 | 6.2 | GO:0086070 | SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.8 | 3.1 | GO:0000902 | cell morphogenesis(GO:0000902) |
0.8 | 2.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.8 | 4.6 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.8 | 5.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.8 | 2.3 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.8 | 3.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.8 | 5.3 | GO:0097484 | dendrite extension(GO:0097484) |
0.8 | 3.8 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.8 | 3.8 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.8 | 5.3 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.7 | 2.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.7 | 1.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.7 | 8.0 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.7 | 2.9 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.7 | 2.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.7 | 3.6 | GO:0015824 | proline transport(GO:0015824) |
0.7 | 15.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.7 | 5.0 | GO:0042426 | choline catabolic process(GO:0042426) |
0.7 | 4.3 | GO:0002784 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.7 | 6.4 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.7 | 0.7 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
0.7 | 2.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.7 | 1.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.7 | 1.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.7 | 6.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.7 | 6.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.7 | 8.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.7 | 4.7 | GO:0034770 | regulation of histone H3-K36 methylation(GO:0000414) histone H4-K20 methylation(GO:0034770) |
0.7 | 1.3 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.7 | 1.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 6.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 4.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.7 | 1.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.7 | 1.3 | GO:0099624 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.7 | 4.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.7 | 5.2 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.6 | 2.6 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.6 | 8.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.6 | 4.5 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.6 | 4.5 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.6 | 2.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 11.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 1.9 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.6 | 42.9 | GO:0070268 | cornification(GO:0070268) |
0.6 | 3.8 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.6 | 4.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.6 | 3.7 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.6 | 2.5 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.6 | 3.7 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.6 | 7.4 | GO:0006909 | phagocytosis(GO:0006909) |
0.6 | 3.1 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.6 | 5.5 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.6 | 4.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.6 | 11.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.6 | 3.6 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.6 | 2.4 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.6 | 12.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.6 | 3.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.6 | 1.8 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.6 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
0.6 | 4.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.6 | 8.2 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.6 | 7.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.6 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 2.3 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.6 | 1.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.6 | 2.9 | GO:0006555 | sulfur amino acid metabolic process(GO:0000096) methionine metabolic process(GO:0006555) |
0.6 | 2.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 4.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.6 | 3.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.6 | 9.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.6 | 4.0 | GO:0071902 | positive regulation of protein serine/threonine kinase activity(GO:0071902) |
0.6 | 11.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.6 | 1.7 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.6 | 5.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.6 | 8.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.5 | 15.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.5 | 4.3 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.5 | 4.3 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.5 | 7.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.5 | 3.2 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.5 | 3.8 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 21.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.5 | 3.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.5 | 3.2 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.5 | 2.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 11.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.5 | 7.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.5 | 7.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.5 | 4.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 3.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.5 | 5.7 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.5 | 1.0 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.5 | 2.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.5 | 4.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 3.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.5 | 4.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 3.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 6.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.5 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 1.0 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.5 | 4.1 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.5 | 2.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.5 | 5.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.5 | 2.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 21.2 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.5 | 2.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.5 | 4.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 1.0 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.5 | 2.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.5 | 2.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 2.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.5 | 3.5 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.5 | 5.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.5 | 4.4 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) positive regulation of killing of cells of other organism(GO:0051712) |
0.5 | 6.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.5 | 3.4 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
0.5 | 3.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.5 | 5.3 | GO:0050802 | circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.5 | 7.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.5 | 1.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.5 | 22.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.5 | 2.9 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.5 | 1.4 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) positive regulation of gastric acid secretion(GO:0060454) response to capsazepine(GO:1901594) |
0.5 | 4.3 | GO:0072164 | ureteric bud development(GO:0001657) mesonephros development(GO:0001823) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.5 | 4.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.5 | 5.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 0.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 6.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.5 | 0.9 | GO:1990637 | response to prolactin(GO:1990637) |
0.5 | 2.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 6.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.5 | 3.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.4 | GO:0072141 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.5 | 1.4 | GO:0042699 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 6.8 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 4.5 | GO:0001553 | luteinization(GO:0001553) |
0.5 | 2.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.4 | 5.8 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.4 | 4.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 4.5 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.4 | 7.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.4 | 7.1 | GO:0050870 | positive regulation of T cell activation(GO:0050870) |
0.4 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.4 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.4 | 3.5 | GO:0001660 | fever generation(GO:0001660) |
0.4 | 6.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.4 | 1.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 1.3 | GO:0032470 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) maintenance of mitochondrion location(GO:0051659) relaxation of skeletal muscle(GO:0090076) |
0.4 | 1.7 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.4 | 6.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.4 | 2.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.4 | 5.1 | GO:0060004 | reflex(GO:0060004) |
0.4 | 3.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 5.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.4 | 0.8 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.4 | 2.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 8.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 9.9 | GO:1903391 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of adherens junction organization(GO:1903391) |
0.4 | 0.8 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 2.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.4 | 2.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 8.6 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.4 | 1.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.4 | 0.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 2.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.4 | 0.4 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.4 | 1.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.4 | 2.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.4 | 1.6 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
0.4 | 4.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.4 | 4.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 2.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 36.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.4 | 4.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.4 | 5.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 2.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.4 | 3.5 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.4 | 5.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.4 | 4.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 1.5 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.4 | 1.9 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.4 | 3.5 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.4 | 0.8 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.4 | 10.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 3.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.4 | 2.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 4.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 4.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.4 | 3.0 | GO:0099612 | protein localization to axon(GO:0099612) |
0.4 | 1.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 0.7 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.4 | 2.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.4 | 1.8 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.4 | 14.6 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.4 | 0.7 | GO:0048665 | neuron fate specification(GO:0048665) |
0.4 | 5.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 1.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.4 | 4.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 1.4 | GO:0048749 | compound eye development(GO:0048749) |
0.4 | 2.8 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
0.4 | 5.7 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.4 | 4.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.3 | 9.4 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.3 | 4.2 | GO:2000615 | histone H3-K9 acetylation(GO:0043970) regulation of histone H3-K9 acetylation(GO:2000615) |
0.3 | 6.2 | GO:0042110 | T cell activation(GO:0042110) T cell aggregation(GO:0070489) |
0.3 | 3.8 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 2.4 | GO:0072017 | distal tubule development(GO:0072017) |
0.3 | 10.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.3 | 9.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.3 | 1.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 2.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 2.7 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 3.0 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.3 | 2.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 6.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 3.0 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 5.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 3.0 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.3 | 2.0 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.3 | 0.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.3 | 1.3 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 3.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 2.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 12.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 1.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.3 | 7.5 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.3 | 14.0 | GO:0046849 | bone remodeling(GO:0046849) |
0.3 | 2.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 2.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.3 | 2.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.3 | 8.6 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.3 | 12.1 | GO:0042552 | myelination(GO:0042552) |
0.3 | 1.0 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.3 | 5.7 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 16.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.3 | 1.6 | GO:1990592 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 4.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.3 | 5.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.3 | 4.7 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.3 | 0.3 | GO:0048521 | negative regulation of behavior(GO:0048521) |
0.3 | 2.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 3.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 2.5 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.3 | 1.9 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.3 | 1.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 1.8 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.3 | 4.2 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.3 | 4.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 3.3 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.3 | 3.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 0.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.3 | 2.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.3 | 8.6 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.3 | 4.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 1.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.3 | 5.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.3 | 13.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 5.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 8.4 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.3 | 6.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 2.0 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 3.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 3.7 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 0.8 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.3 | 1.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.3 | 2.5 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.3 | 1.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.3 | 2.8 | GO:0045778 | positive regulation of ossification(GO:0045778) |
0.3 | 1.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 1.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 149.2 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.3 | 1.1 | GO:0006068 | ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
0.3 | 0.8 | GO:0009624 | response to nematode(GO:0009624) eosinophil differentiation(GO:0030222) |
0.3 | 2.4 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.3 | 2.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 1.9 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 2.7 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.3 | 4.5 | GO:0003170 | heart valve development(GO:0003170) |
0.3 | 2.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 1.6 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 6.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 13.7 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.3 | 8.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 1.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 1.3 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 2.5 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.5 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 7.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.2 | 3.7 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.2 | 5.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 2.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.2 | 1.4 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 21.4 | GO:0050796 | regulation of insulin secretion(GO:0050796) |
0.2 | 0.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.2 | 2.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 2.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.7 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) positive regulation of endocytic recycling(GO:2001137) |
0.2 | 2.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 1.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 1.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.2 | 1.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.9 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.2 | 6.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 3.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 2.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 1.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 6.5 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.2 | 1.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.2 | 1.3 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.2 | 2.6 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.2 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 26.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 1.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.2 | 1.2 | GO:0038111 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.2 | 1.6 | GO:0046463 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.2 | 1.0 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.2 | 3.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 2.4 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.2 | 1.0 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.2 | 0.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 1.0 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 9.5 | GO:0001933 | negative regulation of protein phosphorylation(GO:0001933) |
0.2 | 2.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 2.7 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 8.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 4.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 3.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.9 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 5.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 2.5 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.2 | 3.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 6.0 | GO:0021510 | spinal cord development(GO:0021510) |
0.2 | 0.5 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.2 | 2.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 2.2 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.2 | 1.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 2.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 2.5 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.2 | 6.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 3.0 | GO:0021983 | pituitary gland development(GO:0021983) |
0.2 | 7.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 1.6 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.2 | 0.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 2.9 | GO:1990266 | neutrophil migration(GO:1990266) |
0.2 | 4.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 4.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 2.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 1.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 2.4 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.2 | 0.6 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 3.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 4.0 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 1.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.6 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 1.0 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 2.6 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.1 | 3.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 3.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 1.0 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 3.8 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 1.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 8.8 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.5 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 0.6 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.1 | 3.8 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 1.8 | GO:0003407 | neural retina development(GO:0003407) |
0.1 | 2.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.9 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.9 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 1.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 1.4 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.5 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 1.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 2.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 1.6 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.1 | 1.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.9 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.7 | GO:0050821 | protein stabilization(GO:0050821) |
0.1 | 1.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.4 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 1.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.5 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 1.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.1 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.1 | 0.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 3.1 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 2.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.4 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 2.6 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.2 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 6.2 | GO:0007601 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 1.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 2.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.8 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.1 | GO:0002545 | microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.0 | 0.3 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.2 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 1.0 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 1.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.5 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 1.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0003015 | heart process(GO:0003015) |
0.0 | 0.4 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 1.3 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.3 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.8 | 160.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
15.0 | 60.2 | GO:0070695 | FHF complex(GO:0070695) |
8.2 | 65.3 | GO:0035976 | AP1 complex(GO:0035976) |
7.3 | 109.4 | GO:0005916 | fascia adherens(GO:0005916) |
6.0 | 24.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
5.9 | 29.4 | GO:0005602 | complement component C1 complex(GO:0005602) |
4.8 | 148.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
4.5 | 13.6 | GO:0044609 | DBIRD complex(GO:0044609) |
3.9 | 19.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
3.3 | 39.2 | GO:0043203 | axon hillock(GO:0043203) |
3.1 | 21.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
3.0 | 8.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
3.0 | 14.8 | GO:0045298 | tubulin complex(GO:0045298) |
2.9 | 82.7 | GO:0030057 | desmosome(GO:0030057) |
2.7 | 8.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
2.5 | 35.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
2.5 | 10.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.5 | 52.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.5 | 17.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.4 | 7.3 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
2.4 | 14.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
2.4 | 16.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.3 | 16.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
2.2 | 8.9 | GO:0043293 | apoptosome(GO:0043293) |
2.2 | 4.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
2.2 | 19.4 | GO:0097433 | dense body(GO:0097433) |
2.1 | 17.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.9 | 7.5 | GO:1990745 | EARP complex(GO:1990745) |
1.9 | 7.4 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
1.9 | 3.7 | GO:0045179 | apical cortex(GO:0045179) |
1.8 | 9.1 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
1.8 | 7.1 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
1.7 | 8.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
1.6 | 9.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.6 | 6.4 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
1.6 | 9.4 | GO:1990130 | Iml1 complex(GO:1990130) |
1.6 | 9.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.5 | 38.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.5 | 4.5 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
1.5 | 8.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.4 | 24.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.4 | 12.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
1.3 | 63.0 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
1.3 | 26.8 | GO:0030056 | hemidesmosome(GO:0030056) |
1.3 | 5.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
1.3 | 9.2 | GO:0016342 | catenin complex(GO:0016342) |
1.3 | 2.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.3 | 9.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.3 | 40.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.3 | 6.3 | GO:0016600 | flotillin complex(GO:0016600) |
1.3 | 11.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.2 | 3.6 | GO:0005652 | nuclear lamina(GO:0005652) |
1.2 | 30.0 | GO:0034706 | sodium channel complex(GO:0034706) |
1.1 | 83.2 | GO:0034707 | chloride channel complex(GO:0034707) |
1.1 | 4.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.1 | 6.7 | GO:0033270 | paranode region of axon(GO:0033270) |
1.1 | 3.3 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
1.1 | 9.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.1 | 9.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.1 | 4.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
1.1 | 10.6 | GO:0097449 | astrocyte projection(GO:0097449) |
1.0 | 3.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.0 | 4.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.0 | 9.1 | GO:0005901 | caveola(GO:0005901) |
1.0 | 30.2 | GO:0001533 | cornified envelope(GO:0001533) |
1.0 | 17.1 | GO:0005922 | connexon complex(GO:0005922) |
1.0 | 2.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.0 | 26.0 | GO:0034451 | centriolar satellite(GO:0034451) |
1.0 | 3.8 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.9 | 7.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.9 | 13.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.9 | 4.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.9 | 3.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 5.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.9 | 3.5 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.9 | 8.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.9 | 2.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.9 | 98.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.9 | 4.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.8 | 19.5 | GO:0030673 | axolemma(GO:0030673) |
0.8 | 2.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.8 | 5.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.8 | 5.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.8 | 6.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.8 | 10.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 9.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.8 | 23.8 | GO:0005604 | basement membrane(GO:0005604) |
0.8 | 4.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.8 | 7.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.8 | 6.4 | GO:0005921 | gap junction(GO:0005921) |
0.8 | 6.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.8 | 3.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.8 | 8.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.8 | 5.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.8 | 4.6 | GO:1990037 | Lewy body core(GO:1990037) |
0.8 | 3.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 5.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.8 | 3.8 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.7 | 4.4 | GO:0043218 | compact myelin(GO:0043218) |
0.7 | 4.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 12.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.7 | 4.3 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.7 | 83.9 | GO:0070160 | occluding junction(GO:0070160) |
0.7 | 7.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 29.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.7 | 2.8 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.7 | 3.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.7 | 9.0 | GO:0001741 | XY body(GO:0001741) |
0.7 | 6.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.7 | 16.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.7 | 15.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.7 | 4.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.7 | 11.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 7.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.7 | 4.0 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.7 | 17.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.6 | 13.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.6 | 11.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.6 | 3.7 | GO:0001740 | Barr body(GO:0001740) |
0.6 | 3.1 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 12.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.6 | 16.8 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.6 | 4.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.6 | 7.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 2.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 2.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.6 | 4.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 6.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 2.8 | GO:0089701 | U2AF(GO:0089701) |
0.5 | 1.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 3.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 10.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 3.6 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.5 | 2.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 3.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 1.5 | GO:0071546 | pi-body(GO:0071546) |
0.5 | 16.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 3.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 6.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 2.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.5 | 4.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 24.5 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 3.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.5 | 3.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 9.7 | GO:0046930 | pore complex(GO:0046930) |
0.5 | 18.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 2.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.5 | 3.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.5 | 8.1 | GO:0043235 | receptor complex(GO:0043235) |
0.4 | 23.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 1.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.4 | 5.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 41.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.4 | 4.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 5.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 5.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 1.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.4 | 8.1 | GO:0005605 | basal lamina(GO:0005605) |
0.4 | 13.3 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 16.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 2.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.4 | 17.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 3.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 4.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.4 | 0.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 21.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 13.7 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 1.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 6.5 | GO:0044447 | axoneme part(GO:0044447) |
0.4 | 2.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.4 | 4.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 5.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 70.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 8.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 19.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 503.5 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 5.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.3 | 3.4 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 5.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 1.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 4.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 5.2 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 3.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 11.6 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 17.2 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 0.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 3.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 3.9 | GO:0097227 | sperm annulus(GO:0097227) |
0.3 | 10.5 | GO:0031672 | A band(GO:0031672) |
0.3 | 12.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 1.3 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 1.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.3 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 4.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.2 | 5.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.2 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 11.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.2 | 5.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 5.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 1.6 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.2 | 3.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 2.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 4.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 3.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 2.0 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 13.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.2 | 19.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 12.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 6.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 1.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.4 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 1.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 7.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 2.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 5.7 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 6.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 11.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 1.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 4.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 3.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 1.0 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 309.3 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 2.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 1.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.7 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 1.8 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.3 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.7 | 123.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
9.1 | 27.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
8.4 | 33.8 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
5.6 | 22.5 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
5.3 | 26.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
4.4 | 17.7 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
4.3 | 17.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
4.0 | 12.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
3.7 | 11.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
3.5 | 3.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
3.5 | 13.9 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
3.5 | 13.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
3.4 | 20.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
3.4 | 13.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
3.4 | 17.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
3.4 | 13.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
3.2 | 12.7 | GO:0061714 | folic acid receptor activity(GO:0061714) |
3.1 | 12.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.0 | 9.1 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
3.0 | 14.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
2.9 | 38.3 | GO:0038132 | neuregulin binding(GO:0038132) |
2.9 | 38.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
2.9 | 8.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
2.9 | 8.7 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
2.9 | 8.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.9 | 8.6 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
2.9 | 25.7 | GO:0043426 | MRF binding(GO:0043426) |
2.8 | 8.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
2.8 | 5.6 | GO:0070888 | E-box binding(GO:0070888) |
2.8 | 13.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.6 | 15.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.6 | 10.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.6 | 15.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.5 | 33.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.5 | 10.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
2.5 | 7.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
2.5 | 24.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
2.5 | 7.4 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
2.4 | 12.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
2.4 | 12.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
2.4 | 63.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
2.4 | 19.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.3 | 9.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
2.3 | 6.8 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
2.2 | 13.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
2.2 | 6.6 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
2.2 | 13.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
2.2 | 30.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
2.2 | 6.5 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
2.2 | 19.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.2 | 6.5 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
2.1 | 226.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.1 | 8.5 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
2.1 | 8.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.1 | 8.4 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
2.1 | 6.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
2.1 | 8.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
2.1 | 6.2 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
2.0 | 6.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
2.0 | 8.1 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
2.0 | 20.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.0 | 2.0 | GO:0043199 | sulfate binding(GO:0043199) |
2.0 | 8.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
2.0 | 7.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.9 | 9.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.9 | 7.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.9 | 9.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
1.9 | 25.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.9 | 5.8 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
1.9 | 1.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.9 | 5.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.9 | 7.5 | GO:0016160 | amylase activity(GO:0016160) |
1.9 | 13.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.9 | 42.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.8 | 11.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.8 | 1.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
1.8 | 9.2 | GO:0034046 | poly(G) binding(GO:0034046) |
1.8 | 20.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.8 | 23.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.8 | 10.7 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
1.8 | 5.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.8 | 5.3 | GO:0047223 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
1.7 | 5.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.7 | 8.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
1.7 | 8.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.7 | 5.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.7 | 13.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.6 | 3.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.6 | 4.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.6 | 9.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.6 | 11.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.6 | 12.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.6 | 22.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.6 | 4.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.5 | 38.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.5 | 21.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.5 | 6.1 | GO:0047708 | biotinidase activity(GO:0047708) |
1.5 | 33.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.5 | 10.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.5 | 10.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.5 | 8.9 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
1.5 | 5.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.4 | 13.0 | GO:0016594 | glycine binding(GO:0016594) |
1.4 | 5.8 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
1.4 | 9.9 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.4 | 5.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.4 | 12.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.4 | 70.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.4 | 4.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.4 | 4.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.4 | 15.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.4 | 4.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.4 | 4.1 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
1.4 | 4.1 | GO:0019961 | interferon binding(GO:0019961) |
1.4 | 17.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.4 | 6.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.3 | 12.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
1.3 | 5.3 | GO:0016499 | orexin receptor activity(GO:0016499) |
1.3 | 5.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.3 | 33.0 | GO:0030506 | ankyrin binding(GO:0030506) |
1.3 | 4.0 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.3 | 15.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
1.3 | 6.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
1.3 | 3.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.3 | 7.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.3 | 10.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.3 | 15.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.3 | 10.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.3 | 16.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.3 | 3.8 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
1.3 | 12.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.3 | 6.3 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
1.3 | 10.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.2 | 6.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.2 | 3.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.2 | 3.7 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
1.2 | 1.2 | GO:0050436 | microfibril binding(GO:0050436) |
1.2 | 3.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.2 | 7.3 | GO:0070513 | death domain binding(GO:0070513) |
1.2 | 3.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.2 | 10.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.2 | 3.5 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.2 | 4.7 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.2 | 3.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.1 | 6.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.1 | 3.4 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
1.1 | 11.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.1 | 5.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
1.1 | 3.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.1 | 11.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.1 | 12.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.1 | 5.5 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
1.1 | 17.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.1 | 13.0 | GO:0045159 | myosin II binding(GO:0045159) |
1.1 | 16.2 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
1.1 | 7.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.1 | 14.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.1 | 297.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.0 | 4.2 | GO:0071253 | connexin binding(GO:0071253) |
1.0 | 15.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.0 | 23.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.0 | 5.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.0 | 4.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
1.0 | 99.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.0 | 6.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.0 | 4.1 | GO:0035473 | lipase binding(GO:0035473) |
1.0 | 5.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.0 | 5.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
1.0 | 3.0 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
1.0 | 3.0 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.0 | 12.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 4.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.0 | 4.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
1.0 | 6.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.0 | 3.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.0 | 7.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.0 | 5.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.0 | 2.9 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.0 | 9.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.0 | 5.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
1.0 | 2.9 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
1.0 | 3.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.0 | 6.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.0 | 16.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.9 | 2.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.9 | 3.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.9 | 3.7 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.9 | 2.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.9 | 2.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.9 | 10.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.9 | 24.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.9 | 6.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.9 | 4.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.9 | 5.4 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.9 | 7.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.9 | 24.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.9 | 2.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.9 | 2.7 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) vitamin transmembrane transporter activity(GO:0090482) |
0.9 | 67.1 | GO:0005254 | chloride channel activity(GO:0005254) |
0.9 | 7.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.9 | 5.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.9 | 3.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.9 | 20.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.9 | 2.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.9 | 12.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.9 | 16.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.9 | 2.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.9 | 4.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.8 | 11.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 8.4 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.8 | 12.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.8 | 4.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.8 | 5.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.8 | 6.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 3.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 2.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.8 | 5.7 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.8 | 10.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.8 | 24.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.8 | 5.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.8 | 4.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 6.4 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.8 | 4.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.8 | 2.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.8 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.8 | 4.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.8 | 9.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.8 | 2.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.8 | 5.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.8 | 2.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 42.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.8 | 3.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 3.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.7 | 3.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.7 | 5.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 4.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.7 | 10.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.7 | 13.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.7 | 11.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.7 | 5.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.7 | 5.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.7 | 4.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.7 | 54.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.7 | 5.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.7 | 7.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.7 | 4.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 2.8 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.7 | 21.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.7 | 10.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.7 | 32.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.7 | 3.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.7 | 5.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.7 | 4.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.7 | 9.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.7 | 5.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.7 | 6.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.7 | 35.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.7 | 12.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 18.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.7 | 15.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.7 | 5.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.6 | 2.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.6 | 8.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.6 | 18.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 4.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.6 | 3.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 5.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.6 | 6.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 8.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 10.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 5.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.6 | 1.8 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.6 | 2.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.6 | 6.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.6 | 1.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.6 | 5.4 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.6 | 7.2 | GO:0019864 | IgG binding(GO:0019864) |
0.6 | 1.8 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 2.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 4.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 1.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.6 | 2.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 8.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.6 | 2.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 2.8 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.6 | 9.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 2.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 2.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.6 | 13.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.6 | 14.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 8.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.6 | 1.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 2.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.5 | 9.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 1.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.5 | 1.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 10.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 3.2 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.5 | 3.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 9.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.5 | 5.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 1.6 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.5 | 1.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.5 | 14.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 21.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.5 | 8.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 3.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 2.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 5.9 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.5 | 15.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 8.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.5 | 2.4 | GO:0070404 | NADH binding(GO:0070404) |
0.5 | 4.3 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.5 | 7.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 9.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.5 | 4.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.5 | 46.8 | GO:0005179 | hormone activity(GO:0005179) |
0.5 | 1.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.5 | 3.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 2.3 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.5 | 4.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 5.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.4 | 4.9 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.4 | 12.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.4 | 19.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 4.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.4 | 3.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.4 | 1.3 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.4 | 4.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 7.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.4 | 3.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 2.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.4 | 4.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 5.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 110.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.4 | 2.1 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 13.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.4 | 4.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 11.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 2.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.4 | 3.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 9.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 5.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 2.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 2.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 2.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 0.8 | GO:0030305 | heparanase activity(GO:0030305) |
0.4 | 3.6 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.4 | 2.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.4 | 3.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 19.1 | GO:0004601 | peroxidase activity(GO:0004601) |
0.4 | 2.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 9.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.9 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.4 | 1.1 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 3.6 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 4.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 2.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 4.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 55.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 2.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 12.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.0 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 11.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 4.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 10.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 2.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 4.7 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.3 | 13.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 2.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 4.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 0.9 | GO:0052825 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.3 | 3.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 4.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 3.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 2.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 0.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 1.5 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.3 | 2.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 2.7 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 1.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 2.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 2.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 8.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.3 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 3.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 4.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 8.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 2.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 4.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 5.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.3 | 1.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 6.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 3.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 1.0 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.2 | 12.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 5.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.2 | 2.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 3.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 3.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 10.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 3.3 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 8.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 4.0 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 8.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 3.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.2 | 1.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 2.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 3.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 11.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 6.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 3.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 3.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 2.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 2.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 7.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 1.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 0.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 29.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.2 | 6.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 4.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 1.0 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.2 | 0.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.3 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.2 | 1.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 3.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 1.6 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 2.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 1.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 2.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.0 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 5.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 38.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.4 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 13.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 8.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 4.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 8.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 9.5 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 1.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 6.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 2.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 1.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 1.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 4.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.9 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.1 | 1.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 6.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 7.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 85.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 6.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.0 | GO:0004691 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.1 | 4.4 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 3.6 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 2.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 3.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 69.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.0 | 6.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.9 | 69.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.4 | 32.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.4 | 5.7 | PID ALK1 PATHWAY | ALK1 signaling events |
1.3 | 11.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.3 | 6.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.2 | 33.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.1 | 73.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
1.1 | 92.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.1 | 15.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.1 | 60.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.1 | 34.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.0 | 28.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.9 | 19.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.9 | 6.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.9 | 31.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.9 | 14.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 6.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.8 | 39.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.8 | 19.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.8 | 11.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.8 | 8.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.8 | 4.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.7 | 9.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.6 | 6.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.6 | 10.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 12.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.6 | 27.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.6 | 23.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 11.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.6 | 101.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.6 | 3.5 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 11.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.6 | 14.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.6 | 24.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.6 | 6.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 37.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 26.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.5 | 6.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.5 | 3.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 8.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.5 | 167.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.4 | 6.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 12.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 2.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 4.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 6.7 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 17.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 9.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 17.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 14.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 15.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 4.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 1.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 14.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 9.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 1.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 9.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 9.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 13.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 12.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 28.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 3.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 2.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 2.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 3.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 2.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 3.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 5.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 4.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 6.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 2.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 6.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 3.8 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 8.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 2.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 4.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 25.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 4.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 17.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 85.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
4.1 | 155.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
3.3 | 65.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.8 | 80.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.7 | 29.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.9 | 73.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.7 | 16.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.5 | 16.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.5 | 28.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
1.4 | 27.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
1.3 | 14.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.2 | 27.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.2 | 31.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.2 | 7.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.2 | 64.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.2 | 12.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.1 | 21.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.1 | 38.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.1 | 29.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.0 | 5.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.0 | 9.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.0 | 8.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.0 | 26.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.0 | 21.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.9 | 16.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.9 | 39.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.9 | 48.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.9 | 15.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.8 | 14.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.8 | 11.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 24.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.8 | 6.3 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.8 | 2.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 3.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.7 | 6.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.7 | 14.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.7 | 2.9 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.7 | 12.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.7 | 10.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.7 | 20.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.6 | 20.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.6 | 3.7 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.6 | 26.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.6 | 8.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 3.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 15.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 2.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.6 | 42.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.6 | 24.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 25.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 29.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 9.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.5 | 81.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 47.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 6.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 24.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 9.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.5 | 4.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 11.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 4.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 38.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 8.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 8.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 7.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 15.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 13.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 3.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 6.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 6.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 3.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 15.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.4 | 7.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 18.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 3.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 8.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 34.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 22.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 7.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 2.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 8.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 4.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.3 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 3.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 1.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 4.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 3.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 14.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 5.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 6.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 7.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 9.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 0.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.2 | 4.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 3.8 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.2 | 5.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.2 | 3.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 3.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 1.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 9.5 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.2 | 3.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 3.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 4.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 3.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 1.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 14.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 2.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 2.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.0 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 1.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 20.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 3.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.4 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 2.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.7 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.3 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |